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Cannabinoids are a group of chemical substances that
activate cannabinoid receptors. The general types of
cannabinoids are (1) phyto-cannabinoids, naturally
occurring in the cannabis plant, (2) synthetic cannabi-
noids, produced in the laboratory, and (3) endocannabi-
noids which naturally form endogenously in the body.
The endocannabinoid signalling system is known to
have a neuromodulatory role in many physiological pro-
cesses including neurotransmission, synaptic plasticity,
learning and memory [1]. Endocannabinoids are synthe-
sised in response to neuronal activity in a calcium-
dependent manner and/or due to G protein-coupled
receptor activation. Once released into the synaptic
cleft, they act in a retrograde fashion on pre-synaptic
cannabinoid receptors resulting to inhibition of neuro-
transmitter release. Endocannabinoids are known to
underlie certain forms of short- and long-term forms of
synaptic plasticity at both excitatory and inhibitory
synapses in various brain areas [1]. In hippocampus, a
form of endocannabinoid-mediated short-term depres-
sion (eCB-STD), which is calcium-dependent, is known
as depolarization-induced suppression of inhibition
(DSI) or excitation (DSE) [3]. Both hippocampal DSI
and DSE can be induced by application of cannabinoid
receptor agonists and are blocked by cannabinoid recep-
tor antagonists [2,4]. Although DSI and DSE in hippo-
campus share many common biochemical signalling
pathways, DSE is less prominent than DSI and requires
longer depolarisations for induction supposedly due to
the lower expression and sensitivity of cannabinoid
receptors on excitatory cells [3]. However, the expres-
sion of cannabinoid receptors on excitatory terminals is
more homogeneous than in inhibitory terminals (only
about 50% of inhibitory terminals are sensitive to eCB-
STD) [3].
Here, we present the development of a mathematical
model of the endocannabinoid signalling underlying DSE
at hippocampal excitatory synapses on excitatory cells
which is (a) biophysically plausible, describing the most
essential pathways underlying this phenomenon (b)
detailed enough to describe the key DSE experimental
characteristics, and, (c) is simple enough to use in net-
work studies. The main components of the DSE model
are (i) a post-synaptic single compartment model for the
excitatory cell with endocannabinoid synthesis mediated
by intracellular calcium dynamics, and, (ii) a pre-synaptic
single compartment model for the excitatory cell with
cannabinoid receptor dynamics modulating excitatory
synaptic transmission. As a modelling framework for the
cannabinoid signalling we consider a recently developed
biophysical model for endocannabinoid-mediated short-
term depression of inhibition in hippocampus [5]. We
extend and adapt this model in order to account for the
reduced magnitude and higher induction threshold for
DSE versus DSI. The model successfully reproduces the
mediation of DSE due to endocannabinoid-mobilising sti-
mulation (depolarising voltage pulses), as observed
experimentally [3]. The model also successfully captures
the mediation of endocannabinoid-mediated short-term
depression of excitation due to cannabinoid agonist
administration (WIN55,212) [3]. The development of the
DSE model opens the way for comprehensive networks
studies including both DSI and DSE, in order to decipher
the role of cannabinoids in synaptic transmission in net-
work emergent behaviour related to memory and
learning.
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